Travere Therapeutics Inc

  • TickerTVTX
  • ISINUS89422G1076
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States
 PRESS RELEASE
TVTX Travere Therape... (Health Care)

Travere Therapeutics to Report Second Quarter 2021 Financial Results

Travere Therapeutics to Report Second Quarter 2021 Financial Results SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter 2021 financial results on Thursday, July 29, 2021 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. Conference Call Information Date:Thursday, July 29, 2021Time:4:30 p.m. ETDial-in numbers:+1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)Confi...

 PRESS RELEASE
TVTX Travere Therape... (Health Care)

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Ru...

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN DIEGO, July 14, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on July 10, 2021, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 89,950 shares of its common stock to eleven new employees, consisting of inducement stock options to purchase an aggregate of 65,100 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 24,850 shares of its common stock. These indu...

 PRESS RELEASE
TVTX Travere Therape... (Health Care)

Travere Therapeutics to Present at Upcoming Investor Conferences

Travere Therapeutics to Present at Upcoming Investor Conferences SAN DIEGO, May 27, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the following upcoming virtual investor conferences in June: Jefferies Virtual Healthcare Conference Date: Wednesday, June 2, 2021Time: 1:00 p.m. ET JMP Securities Life Sciences Conference Date: Wednesday, June 16, 2021Time: 11:00 a.m. ET BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology Date: Tuesday, June 22, 2021Time: 11:15 a.m. ET Live webcasts will be available at...

Laura Chico ... (+2)
  • Laura Chico
  • Kenneth Shields
Laura Chico ... (+2)
  • Laura Chico
  • Kenneth Shields
 PRESS RELEASE
TVTX Travere Therape... (Health Care)

Travere Therapeutics to Report Second Quarter 2021 Financial Results

Travere Therapeutics to Report Second Quarter 2021 Financial Results SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter 2021 financial results on Thursday, July 29, 2021 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. Conference Call Information Date:Thursday, July 29, 2021Time:4:30 p.m. ETDial-in numbers:+1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)Confi...

 PRESS RELEASE
TVTX Travere Therape... (Health Care)

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Ru...

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN DIEGO, July 14, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on July 10, 2021, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 89,950 shares of its common stock to eleven new employees, consisting of inducement stock options to purchase an aggregate of 65,100 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 24,850 shares of its common stock. These indu...

 PRESS RELEASE
TVTX Travere Therape... (Health Care)

Travere Therapeutics to Present at Upcoming Investor Conferences

Travere Therapeutics to Present at Upcoming Investor Conferences SAN DIEGO, May 27, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the following upcoming virtual investor conferences in June: Jefferies Virtual Healthcare Conference Date: Wednesday, June 2, 2021Time: 1:00 p.m. ET JMP Securities Life Sciences Conference Date: Wednesday, June 16, 2021Time: 11:00 a.m. ET BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology Date: Tuesday, June 22, 2021Time: 11:15 a.m. ET Live webcasts will be available at...

Laura Chico ... (+2)
  • Laura Chico
  • Kenneth Shields
Laura Chico ... (+2)
  • Laura Chico
  • Kenneth Shields
 PRESS RELEASE
TVTX Travere Therape... (Health Care)

Travere Therapeutics to Report Second Quarter 2021 Financial Results

Travere Therapeutics to Report Second Quarter 2021 Financial Results SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report second quarter 2021 financial results on Thursday, July 29, 2021 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. Conference Call Information Date:Thursday, July 29, 2021Time:4:30 p.m. ETDial-in numbers:+1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)Confi...

 PRESS RELEASE
TVTX Travere Therape... (Health Care)

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Ru...

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN DIEGO, July 14, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on July 10, 2021, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 89,950 shares of its common stock to eleven new employees, consisting of inducement stock options to purchase an aggregate of 65,100 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 24,850 shares of its common stock. These indu...

 PRESS RELEASE
TVTX Travere Therape... (Health Care)

Travere Therapeutics to Present at Upcoming Investor Conferences

Travere Therapeutics to Present at Upcoming Investor Conferences SAN DIEGO, May 27, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the following upcoming virtual investor conferences in June: Jefferies Virtual Healthcare Conference Date: Wednesday, June 2, 2021Time: 1:00 p.m. ET JMP Securities Life Sciences Conference Date: Wednesday, June 16, 2021Time: 11:00 a.m. ET BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology Date: Tuesday, June 22, 2021Time: 11:15 a.m. ET Live webcasts will be available at...

Laura Chico ... (+2)
  • Laura Chico
  • Kenneth Shields
Laura Chico ... (+2)
  • Laura Chico
  • Kenneth Shields

ResearchPool Subscriptions

Get the most out of your insights

Get in touch